PRF Technologies (PRFX) Depreciation & Amortization (CF) (2021 - 2024)
PRF Technologies' (PRFX) quarterly Depreciation & Amortization (CF) came in at $4000.0 in Q1 2024, up 100.0% YoY from $2000.0 in Q2 2023, and down 33.33% on a QoQ basis from $6000.0 in Q4 2023.
PRF Technologies (PRFX) Depreciation & Amortization (CF) (2021 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $4000.0 in Q1 2024.
- Quarterly Depreciation & Amortization (CF) rose 100.0% year-over-year to $4000.0 in Q1 2024, while the trailing twelve-month figure through Jun 2025 was $4000.0 (down 69.23% YoY) and the FY2025 annual result came in at $15000.0, down 6.25% from the prior year.
- Depreciation & Amortization (CF) fell to $4000.0 in Q1 2024, from $6000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $7000.0 in Q3 2022 to a low of $1000.0 in Q1 2021.
- A 4-year average of $3416.7 and a median of $3000.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 250.0% — and 2023, when it plunged 57.14%.
- Tracing PRFX's Depreciation & Amortization (CF) over 4 years: stood at $3000.0 in 2021, then surged by 100.0% to $6000.0 in 2022, then changed by 0.0% to $6000.0 in 2023, then plunged by 33.33% to $4000.0 in 2024.
- The last three Depreciation & Amortization (CF) figures came in at $4000.0 (Q1 2024), $6000.0 (Q4 2023), and $3000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |